Suppression of Hypoxia-inducible Factor 1α (HIF-1α) Transcriptional Activity by the HIF Prolyl Hydroxylase EGLN1
Kenneth K.W. To(Riverview Hospital), Eric Huang(University of California, San Francisco)
Cited by 113
Related Papers
MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside
|World Journal of Gastroenterology|2018|205
Small-molecule agents for cancer immunotherapy
|Acta Pharmaceutica Sinica B|2023|53
Targeting the <scp>ABCG</scp>2‐overexpressing multidrug resistant (<scp>MDR</scp>) cancer cells by <scp>PPAR</scp>γ agonists
|British Journal of Pharmacology|2013|35
De novo design of high-affinity protein binders to bioactive helical peptides
|bioRxiv (Cold Spring Harbor Laboratory)|2022|22